If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> European Edition<br /> GASTROENTEROLOGY<br /> Suppl. 2 March 2020 emjreviews.com<br /> + ECCO 2020<br /> New Dimensions:<br /> Exploring Recent Data<br /> and Measures in IBD<br /> 20 20 Vision in IBD<br /> New Dimensions:<br /> Exploring Recent Data and Measures in IBD<br /> This symposium took place on 13th February 2020, as part of the 15th<br /> Congress of the European Crohn's and Colitis Organisation<br /> (ECCO) in Vienna, Austria<br /> Chairperson: Séverine Vermeire1<br /> Speakers: Matthieu Allez,2 Alessandro Armuzzi,3 Séverine Vermeire1<br /> 1. University Hospitals Leuven, Leuven, Belgium<br /> 2. Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris (AP–HP), Paris, France<br /> 3. Fondazione Policlinico Agostino Gemelli IRCCS, Catholic University, Rome, Italy<br /> Disclosure: Prof Allez has received research support, ac<a title="EMJ Gastroenterology 2020 Suppl 2 page 1" href="http://viewer.zmags.com/publication/0e44e1ad?page=1"> European Edition GASTROENTEROLOGY Suppl. 2 </a> <a title="EMJ Gastroenterology 2020 Suppl 2 page 2" href="http://viewer.zmags.com/publication/0e44e1ad?page=2"> New Dimensions: Explorin</a> <a title="EMJ Gastroenterology 2020 Suppl 2 page 3" href="http://viewer.zmags.com/publication/0e44e1ad?page=3"> ustekinumab was associated with higher rates of e</a> <a title="EMJ Gastroenterology 2020 Suppl 2 page 4" href="http://viewer.zmags.com/publication/0e44e1ad?page=4"> STRIDE establishes targets for clinical and endos</a> <a title="EMJ Gastroenterology 2020 Suppl 2 page 5" href="http://viewer.zmags.com/publication/0e44e1ad?page=5"> 55% of patients achieved remission or had mild di</a> <a title="EMJ Gastroenterology 2020 Suppl 2 page 6" href="http://viewer.zmags.com/publication/0e44e1ad?page=6"> Endoscopic improvement Mayo endoscopy score o</a> <a title="EMJ Gastroenterology 2020 Suppl 2 page 7" href="http://viewer.zmags.com/publication/0e44e1ad?page=7"> Clinical/PRO • Rectal bleeding • Bowel habits </a> <a title="EMJ Gastroenterology 2020 Suppl 2 page 8" href="http://viewer.zmags.com/publication/0e44e1ad?page=8"> 8. Battat R et al. Histologic healing </a> <a title="EMJ Gastroenterology 2020 Suppl 2 page 9" href="http://viewer.zmags.com/publication/0e44e1ad?page=9"> 20 20 Vision in IBD This symposium took pl</a> <a title="EMJ Gastroenterology 2020 Suppl 2 page 10" href="http://viewer.zmags.com/publication/0e44e1ad?page=10"> showed that 75.0% and 87.0% of all patients recei</a> <a title="EMJ Gastroenterology 2020 Suppl 2 page 11" href="http://viewer.zmags.com/publication/0e44e1ad?page=11"> and normalisation of bowel habits, as well as a </a> <a title="EMJ Gastroenterology 2020 Suppl 2 page 12" href="http://viewer.zmags.com/publication/0e44e1ad?page=12"> SES-CD improvement >25% Patients (%) 100 90 80 </a> <a title="EMJ Gastroenterology 2020 Suppl 2 page 13" href="http://viewer.zmags.com/publication/0e44e1ad?page=13"> therapies, a clinically meaningful proportion of </a> <a title="EMJ Gastroenterology 2020 Suppl 2 page 14" href="http://viewer.zmags.com/publication/0e44e1ad?page=14"> References 1. Neurath MF. Cytokines in </a>